Neuralink Prepares for Human Trials of AI Brain Implant

Thumbnail Image

The information displayed in the AIM should not be reported as representing the official views of the OECD or of its member countries.

Elon Musk's Neuralink is preparing to begin human clinical trials of its AI-enabled brain chip, hiring a clinical trial director to oversee the process. While no harm has yet occurred, the invasive technology poses plausible health and ethical risks to participants, highlighting potential hazards associated with AI-human brain interfaces.[AI generated]

Why's our monitor labelling this an incident or hazard?

The article discusses Neuralink's hiring of a clinical trial director as it prepares for human trials of brain-implant chips that use AI to interpret neural signals. Although no incident or harm has occurred yet, the imminent human implantation of AI-driven neural devices carries plausible risks of injury or other harms. The event is about the development and planned use of an AI system with potential for harm, fitting the definition of an AI Hazard rather than an Incident or Complementary Information.[AI generated]
AI principles
SafetyPrivacy & data governanceRespect of human rightsRobustness & digital securityTransparency & explainabilityAccountabilityDemocracy & human autonomyHuman wellbeing

Industries
Healthcare, drugs, and biotechnologyRobots, sensors, and IT hardwareDigital security

Affected stakeholders
Consumers

Harm types
Physical (injury)PsychologicalHuman or fundamental rights

Business function:
Research and developmentMonitoring and quality control

AI system task:
Recognition/object detectionOther


Articles about this incident or hazard